| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Beone Medicines Ltd. (ONC) has 8 insiders with recent SEC Form 4 filings, including 1 buy and 81 sells. ONC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 4.58M | $1.25B | - | |
| Pres | 1.45M | $394.50M | - | |
| VP | 97.0K | $26.37M | - | |
| CEO | 3.3K | $888.2K | - | |
| Dir | 2.6K | $714.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2022 | Wu Xiaobin54 | President, COO &Gm China | Sell | 3,410 | $141.99 | $484,201.59 | -100% | +18.1% | +63.4% | |
| May 5, 2022 | Wu Xiaobin54 | President, COO &Gm China | Sell | 6,725 | $164.35 | $1,105,275.80 | -33.6% | +6.4% | +56.6% | |
| Dec 14, 2021 | Huang Jane81 | CMO, Hematology | Sale+OE | 1,500 | $278.14 | $417,211.00 | -34.1% | -47.3% | -24.9% | |
| Dec 1, 2021 | Huang Jane81 | CMO, Hematology | Sell | 1,049 | $359.86 | $377,492.69 | -66.9% | -38.6% | -44.7% | |
| Nov 17, 2021 | Huang Jane81 | CMO, Hematology | Sale+OE | 1,500 | $381.34 | $572,003.39 | -20.5% | -42.2% | -47.2% | |
| Nov 9, 2021 | Wu Xiaobin54 | President, COO &Gm China | Sell | 10,000 | $358.27 | $3,582,663.44 | -12.3% | -40.8% | -52.3% | |
| Nov 8, 2021 | Wang Xiaodong58 | Director, Chair, Scientific Advisory Brd | Sell | 4,500 | $349.81 | $1,574,148.08 | -15.4% | -37.4% | -45.9% | |
| Nov 8, 2021 | Wang Xiaodong58 | Director, Chair, Scientific Advisory Brd | Sell | 4,500 | $350.04 | $1,575,202.00 | -14.9% | -37.4% | -45.9% | |
| Oct 19, 2021 | Huang Jane81 | CMO, Hematology | Sale+OE | 1,500 | $372.78 | $559,163.00 | -24.2% | -36.3% | -58.8% | |
| Sep 24, 2021 | Beigene, Ltd. | 10% Owner | Buy | 2,543,800 | $2.85 | $7,249,830.00 | +52.9% | -29.2% | -63.5% |